Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04827992
NA

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

This study will use a randomized controlled design to test whether medical marijuana use by adults on high-dose chronic opioid therapy (COT) for chronic non-cancer pain is associated with reduced opioid dose and improved pain intensity and interference when added to a 24-week behavioral intervention (POTS).

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

87

Start Date

2021-08-23

Completion Date

2025-10-31

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Cannabis

Participants assigned to the cannabis group were allowed to initiate cannabis use immediately. Participants selected cannabis product type(s), dose(s), and frequency of use from commercial sources.

BEHAVIORAL

Prescription Opioid Taper Support (POTS)

All participants were offered weekly group Prescription Opioid Taper Support (POTS) sessions for 24 weeks. POTS is behavioral intervention promoting pain self-management and gradual, voluntary opioid tapering. This intervention was adapted for this trial to include group-based delivery. Sessions are one hour delivered via teleconference and incorporated cognitive behavioral, mindfulness-based, and motivational interviewing strategies.

Locations (3)

Maine Medical Center

Portland, Maine, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Cambridge Health Alliance

Cambridge, Massachusetts, United States